Question 1 · 274 words written
1. क्या इस अध्ययन में डॉ. सिंह की भागीदारी उचित है? अपना औचित्य सिद्ध कीजिए। 2. क्या डॉ. सिंह हितों के टकराव से जुड़े हैं? यदि हां, तो ऐसे टकराव की प्रकृति क्या है? इसका शमन कैसे किया जा सकता है। 3. यदि उनके नाम पहले से ही शेयर नहीं होते तथा उक्त अध्ययन के संचालन के एवज में शेयर का प्रस्ताव किया गया होता तो हितों के टकराव की प्रकृति किस प्रकार अलग होती?
Opening · no separate opening
None written.
Body · points
(1) No, Dr. Singh's participation in this study is not appropriate due to the following reasons - → Even though he knows that the drug has high chances of succeeding, there is a chance that it might fail. → He is lured into the trial by the firm by offering 25 lakhs for each patient enrolled. This goes against his professional ethics of financial propriety and integrity to the medical organisation he is a part of. → He enjoys the trust of a larger number of patients with MI
and he can't misuse this trust for his monetary benefits. → Fame and money should not be the driving force for a doctor, ethics of care should be.
(2) Yes. There is a conflict of interest between his personal interest of monetary benefit and the interest of his patients who might be at the receiving end of a failed medical trial. Also if the drug succeeds, stocks of his firm will gain. It can be mitigated by Dr. Singh taking a stand for the patients, upholding the professional values of medicine and the Hippocratic oath he took when he started practising medicine - to give
precedence to the health of patient matter what. He can't be part of a randomised double-blinded clinical trial that will impact the life of patients.
(3) The nature of the conflict of interest would be the same as both involve some or the other kind of monetary compensation.
Close
The only glitch would have been that Mr. Singh would have given his participation in the trial one extra thought as he is not directly responsible for the firm's profit or loss.